According to Bain & Company, 2019 produced 42 sponsor deals in HCIT, up from 32 in 2018, with a disclosed value of $17.1 billion, up from $8.3 billion, the report said. 

“The interest in HCIT is pretty wide-sweeping,” said Kara Murphy, a partner with Bain & Company and co-author of the report. 

Murphy spoke specifically to the excitement around companies incorporating data as part of their competitive advantage. Whether that’s care management, drug development, financial services or alternative site electronic medical records, investors are making derivative plays of high-growth sectors as they think through how to use data to make processes faster, she said.